These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 15926166)

  • 1. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
    van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
    Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
    Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
    Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N
    Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia.
    van der Sluis IM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM
    J Pediatr; 2002 Aug; 141(2):204-10. PubMed ID: 12183715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
    Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
    Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peak bone mineral density, lean body mass and fractures.
    Boot AM; de Ridder MA; van der Sluis IM; van Slobbe I; Krenning EP; Keizer-Schrama SM
    Bone; 2010 Feb; 46(2):336-41. PubMed ID: 19833245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood.
    van der Sluis IM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM
    Med Pediatr Oncol; 2000 Oct; 35(4):415-20. PubMed ID: 11025472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density in long-term survivors of childhood cancer.
    Hesseling PB; Hough SF; Nel ED; van Riet FA; Beneke T; Wessels G
    Int J Cancer Suppl; 1998; 11():44-7. PubMed ID: 9876477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the treatment for childhood solid tumors associated with lower bone mass than that for leukemia and Hodgkin disease?
    Muszynska-Roslan K; Konstantynowicz J; Panasiuk A; Krawczuk-Rybak M
    Pediatr Hematol Oncol; 2009 Jan; 26(1):36-47. PubMed ID: 19206007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral density and body composition in adolescents with childhood-onset growth hormone deficiency.
    Boot AM; van der Sluis IM; Krenning EP; de Muinck Keizer-Schrama SM
    Horm Res; 2009; 71(6):364-71. PubMed ID: 19506395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood.
    Brennan BM; Rahim A; Adams JA; Eden OB; Shalet SM
    Br J Cancer; 1999 Apr; 79(11-12):1859-63. PubMed ID: 10206305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemia.
    Hartman A; te Winkel ML; van Beek RD; de Muinck Keizer-Schrama SM; Kemper HC; Hop WC; van den Heuvel-Eibrink MM; Pieters R
    Pediatr Blood Cancer; 2009 Jul; 53(1):64-71. PubMed ID: 19283791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone mineral density in children before and after completion of cancer treatment].
    Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M; Kaczmarski M; Piotrowska-Jastrzebska J
    Pol Merkur Lekarski; 2004 Jul; 17(97):37-42. PubMed ID: 15559608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal morbidity in childhood acute lymphoblastic leukemia.
    Mandel K; Atkinson S; Barr RD; Pencharz P
    J Clin Oncol; 2004 Apr; 22(7):1215-21. PubMed ID: 15051768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of adult height in childhood acute lymphoblastic leukemia survivors after prophylactic cranial irradiation.
    Bongers ME; Francken AB; Rouwé C; Kamps WA; Postma A
    Pediatr Blood Cancer; 2005 Aug; 45(2):139-43. PubMed ID: 15714445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of growth hormone therapy on bone mass, metabolic balance, and well-being in young adult survivors of childhood acute lymphoblastic leukemia.
    van den Heijkant S; Hoorweg-Nijman G; Huisman J; Drent M; van der Pal H; Kaspers GJ; Delemarre-van de Waal H
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):e231-8. PubMed ID: 21792029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopenia, physical activity and health-related quality of life in survivors of brain tumors treated in childhood.
    Odame I; Duckworth J; Talsma D; Beaumont L; Furlong W; Webber C; Barr R
    Pediatr Blood Cancer; 2006 Mar; 46(3):357-62. PubMed ID: 16035080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mass and body composition after cessation of therapy for childhood cancer.
    Nysom K; Mølgaard C; Holm K; Hertz H; Michaelsen KF
    Int J Cancer Suppl; 1998; 11():40-3. PubMed ID: 9876476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body composition and bone mass in survivors of childhood cancer.
    Muszynska-Roslan K; Konstantynowicz J; Krawczuk-Rybak M; Protas P
    Pediatr Blood Cancer; 2007 Feb; 48(2):200-4. PubMed ID: 16602116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.